APO-AZITHROMYCIN - Medsafe
NEW ZEALAND DATA SHEET APO-AZITHROMYCIN Please refer to Medsafe website (www.medsafe.govt.nz) for the most recent datasheet Page 1 of 21 1. APO-AZITHROMYCIN (250mg and 500mg tablets)
Download APO-AZITHROMYCIN - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
PEDIATRIC ANTIBIOTIC DOSING CHART*
www.blessing.org*This clinical guide is provided for information purposes only and is not a substitute for the practitioner’s judgment. Concentrations provided
MSDS - Azithromycin Tablets 250 mg and 500 mg - June 2015
www.lupinpharmaceuticals.comMSDS : 122/00 Page 1 of 5
Aerius Tablets and Syrup - Medicines
www.medicines.org.auPRODUCT INFORMATION AERIUS® TABLETS AND SYRUP NAME OF DRUG Desloratadine DESCRIPTION AERIUS tablets contain desloratadine 5mg and the following inactive ingredients:
Azithromycin 500mg Powder for Solution for Infusion PL ...
www.mhra.gov.ukUKPAR Azithromycin 500mg Powder for Solution for Infusion PL 10622/0306 5 Complete cross-resistance exists among Streptococcus pneumoniae, beta-haemolytic streptococcus of group A, Enterococcus faecalis and Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) to erythromycin, azithromycin, other macrolides and lincosamides.
PRESCRIBING POLICIES: 4.6 PHARMACIST-MANAGED IV-PO ...
www.vhpharmsci.com20 PHARMACIST-MANAGED IV-PO CONVERSION PROGRAM cont’d Group 2 (lower AUC achieved with oral dosage form of same drug) Note: Patient must be clinically improving prior to step-down acyclovir will be converted to valACYclovir
ZAMBIA ESSENTIAL MEDICINE LIST (ZEML) - WHO
www.who.intDrug Presentation Level VEN 2. Drugs acting on the gastrointestinal system 2.1 Antacids 2.1.1 Aluminium hydroxide gel, chewable tablets I-IV E
Medicines and Allied Substances for Human Use - ZAMRA
www.zamra.co.zmCOD Dosage Form: MA. No. 2015 Register of Markerting Authorisations Medicines and Allied Substances for Human Use 33: Adco - Efavirenz 600 tablets Efavirenz POM: Tablet Film coated 111/030